| Description |
1 online resource (xii, 215 pages) : illustrations |
| Contents |
Frontmatter -- Preface -- Content -- Authors Index -- Section 1: History of Extracorporeal Photopheresis -- Section 2: Technical Aspects -- Section 3: Mechanisms of Action of ECP -- Section 4: Extracorporeal Photopheresis in Acute Graft-versus-Host Disease -- Section 5: Extracorporeal Photopheresis in Chronic Graft-versus-Host Disease -- Section 6: ECP for the Prevention of Graft-versus-Host Disease -- Section 7: ECP in Cutaneous T Cell Lymphoma -- Section 8: ECP in Scleroderma and Other Skin Diseases -- Section 9: ECP in Crohn's Disease -- Section 10: Extracorporeal Photopheresis after Solid Organ/Tissue Transplantation -- Section 11: ECP in Diabetes Mellitus -- Section 12: Side Effects of Extracorporeal Photopheresis -- Section 13: Summary |
| Summary |
Extracorporeal photopheresis (ECP) is the first FDA approved cellular photoimmunotherapy for cancer and has demonstrated efficacy in T-cell mediated disorders including prevention and treatment of acute and chronic graft-versus-host disease, organ transplant rejection, scleroderma, Crohn's disease and diabetes mellitus. Due to its exceptional safety profile ECP has gained wide international acceptance through the efforts of leading clinical investigators. Exciting preclinical data and clinical observations provide insight into the mechanisms of action of ECP and are the basis for further clini |
| Bibliography |
Includes bibliographical references |
| Notes |
English |
|
Print version record |
| Subject |
Photochemotherapy.
|
|
Cancer -- Treatment.
|
|
Graft vs Host Disease -- therapy
|
|
Immunotherapy -- methods
|
|
Lymphoma, T-Cell, Cutaneous -- therapy
|
|
Photopheresis -- methods
|
|
Photochemotherapy
|
|
HEALTH & FITNESS -- Diseases -- Cancer.
|
|
MEDICAL -- Oncology.
|
|
Cancer -- Treatment
|
|
Photochemotherapy
|
| Form |
Electronic book
|
| Author |
Greinix, Hildegard T
|
|
Knobler, Robert
|
| LC no. |
2012538036 |
| ISBN |
9783110276138 |
|
3110276135 |
|
